{
  "case_id": "Case_11",
  "model_id": "meta-llama/llama-3.2-3b-instruct",
  "content": "{\n    \"primary_diagnosis\": {\n        \"name\": \"G6PD Deficiency\",\n        \"confidence\": 0.8,\n        \"icd_code\": \"E52.9 (Unknown)\",\n        \"reasoning\": \"Patient's ethnic background from the Middle East and symptoms of hemolysis (yellowing of skin and sclera, dark urine, fatigue, shortness of breath, rapid heart rate) are highly suggestive of G6PD deficiency, a genetic disorder that can cause hemolytic anemia\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Hepatocellular Carcinoma\",\n            \"confidence\": 0.2,\n            \"icd_code\": \"C22.0 (Unknown)\",\n            \"reasoning\": \"Although the patient's symptoms could be related to hepatocellular carcinoma, the lack of specific symptoms such as weight loss, abdominal pain, or liver tenderness makes this less likely\"\n        },\n        {\n            \"name\": \"Medication-Induced Hemolysis\",\n            \"confidence\": 0.6,\n            \"icd_code\": \"R59.2 (Unknown)\",\n            \"reasoning\": \"The patient's recent initiation of semaglutide may have caused hemolytic anemia, but the presence of G6PD deficiency is a more likely explanation for the patient's symptoms\"\n        },\n        {\n            \"name\": \"Anemia of Chronic Disease\",\n            \"confidence\": 0.1,\n            \"icd_code\": \"D50.9 (Unknown)\",\n            \"reasoning\": \"The patient's anemia could be related to chronic disease, but the acute onset of symptoms and lack of other supporting evidence make this a less likely explanation\"\n        }\n    ],\n    \"key_findings\": [\n        \"jaundice\",\n        \"mild splenomegaly\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Complete Blood Count (CBC)\",\n            \"purpose\": \"To rule out anemia and hemolysis\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Liver Function Tests (LFTs)\",\n            \"purpose\": \"To evaluate liver function\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Glucose-6-Phosphate Dehydrogenase (G6PD) test\",\n            \"purpose\": \"To diagnose G6PD deficiency\",\n            \"priority\": \"urgent\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Stop semaglutide immediately\",\n            \"Administer antioxidant medications (e.g., N-acetylcysteine) to prevent further hemolysis\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"N-acetylcysteine\",\n                \"dose\": \"500mg PO every 4 hours\",\n                \"route\": \"PO\",\n                \"duration\": \"until symptoms resolve\",\n                \"rationale\": \"To prevent further hemolysis\"\n            }\n        ],\n        \"monitoring\": [\n            \"Hemoglobin and hematocrit levels\",\n            \"Liver function tests\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Hematology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"To confirm diagnosis and manage G6PD deficiency\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Acute hemolysis\",\n        \"Rapid heart rate\"\n    ],\n    \"patient_education\": [\n        \"G6PD deficiency is a genetic disorder that can cause hemolytic anemia\",\n        \"Symptoms may be triggered by certain medications, including semaglutide\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Within 1 week\",\n        \"conditions\": \"G6PD deficiency, hemolytic anemia\"\n    },\n    \"confidence_in_assessment\": 0.8,\n    \"uncertainties\": [\n        \"Confirm G6PD deficiency diagnosis\",\n        \"Risk of bleeding with anticoagulation medications\"\n    ]\n}",
  "latency": 4.231353998184204,
  "timestamp": "2025-08-10T01:27:40.423853",
  "cached_at": "2025-08-10T01:27:40.423859"
}